ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

ARDELYX, INC.

ARDX

$3.28

+$0.02 (+0.68%)

Price as of Oct 9, 2026 18:39 UTC

930 M

Market Cap (Small Cap)

20%

IV Rank

69.6%

Implied Volatility

Oct 28

Next Earnings

Technical Signals as of Oct 7
Bearish
0 of 7

Trend

  • Above 20-day average $3.47
  • Above 50-day average $3.89
  • Above 200-day average $5.10 · -36.1%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 89d ago

Volume

  • Below-average volume 1.2x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

25.50

Bearish skew

Implied Volatility

69.6%

0% percentile

IV vs Realized

Options rich

30d HV 27.8%

Options Heat Map

Delta-risk grid for ARDX options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

5 buys 93 sells
Date Insider Title Type Shares Value Since Trade
Aug 21, 2026 Foster Eric Duane Sell 2,575 $9,932 -15.2%
Aug 21, 2026 Brady James Parker Sell 1,976 $7,621 -15.2%
Aug 21, 2026 Williams Laura A Sell 2,430 $9,372 -15.2%
Aug 21, 2026 Hohenleitner Susan Sell 1,558 $6,009 -15.2%
Aug 21, 2026 RAAB MICHAEL Sell 15,009 $57,888 -15.2%
Aug 21, 2026 Kelliher Mike Sell 2,652 $10,229 -15.2%
Aug 21, 2026 Williams Laura A Sell 1,734 $6,688 -15.2%
Aug 21, 2026 Williams Laura A Sell 3,486 $13,445 -15.2%
Aug 21, 2026 Williams Laura A Sell 3,089 $11,914 -15.2%
Aug 21, 2026 Bishop John E Sell 2,469 $9,523 -15.2%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 06, 2026 Q2 2026 -$0.06
Aug 03, 2026 Q2 2026 -$0.05
Jul 30, 2026 Q2 2026 -$0.05
Mar 31, 2026 Q1 2026 -$0.15 -$0.15 -1.4% Miss
Dec 31, 2025 Q4 2025 $0.01 $0.00 -100.0% Miss
Sep 30, 2025 Q3 2025 -$0.06 $0.00 +100.0% Beat
Jun 30, 2025 Q2 2025 -$0.14 -$0.08 +41.3% Beat

Track ARDX with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ARDX and your entire portfolio.